We are live on ! Find out more
BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

37 hedge funds and large institutions have $16M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more call options, than puts

Call options by funds: $10.3M | Put options by funds: $3.75M

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

16% more funds holding

Funds holding: 32 → 37 (+5)

11.24% less ownership

Funds ownership: 19.44% → 8.2% (-11%)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

71% less capital invested

Capital invested by funds: $54.6M → $16M (-$38.7M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
37
Holders Change
+5
Holders Change %
+15.63%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
6
Reduced
10
Closed
6
Calls
$10.3M
Puts
$3.75M
Net Calls
+$6.57M
Net Calls Change
+$6.17M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$2.49M
2
OMC
Old Mission Capital
Illinois
+$1.3M
3
Simplex Trading
Simplex Trading
Illinois
+$630K
4
HF
HRT Financial
New York
+$567K
5
Jane Street
Jane Street
New York
+$547K

Top Sellers

Rank Fund Capital Flow
1
HCM
Howard Capital Management
Georgia
-$19.9M
2
GWM
Geneos Wealth Management
Colorado
-$17.4M
3
OPS
Orion Portfolio Solutions
Nebraska
-$1.3M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.09M
5
TFA
Toth Financial Advisory
Virginia
-$962K
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
26
Truvestments Capital
Florida
$16K – – –
SFM
27
Signet Financial Management
New Jersey
$16K +$17.1K +200 New
CAPTRUST Financial Advisors
28
CAPTRUST Financial Advisors
North Carolina
$15K – – –
MCM
29
MV Capital Management
Maryland
$12K – – –
GWM
30
Geneos Wealth Management
Colorado
$8K -$17.4M -202,776 -100%
AW
31
Avion Wealth
Texas
$5K – – –
S
32
SignatureFD
Georgia
$4K +$4.28K +50 New
AF
33
Allworth Financial
California
$3K – – –
TCM
34
Tradewinds Capital Management
Washington
$2K – – –
GEA
35
Glen Eagle Advisors
New Jersey
$1.22K +$1.28K +15 New
HCM
36
Howard Capital Management
Georgia
– -$19.9M -209,901 Closed
OPS
37
Orion Portfolio Solutions
Nebraska
– -$1.3M -13,707 Closed
SW
38
SteelPeak Wealth
California
– -$223K -2,350 Closed
SW
39
SVB Wealth
Massachusetts
– -$142K -1,500 Closed
RCA
40
Ranch Capital Advisors
Florida
– -$28K -296 Closed
ODG
41
O'Dell Group
Ohio
– -$600 -7 -70%
1
2

BIB Hedge Fund Activity: Q4 2021 in Review

37 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q4 2021, worth a combined $16M — down 71% from $54.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BIB positions and 6 closed out — a net gain of 6 holders — while 6 added to existing stakes and 10 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $2.49M. The largest seller was Howard Capital Management, exiting entirely with an estimated $19.9M sold.

  • 37 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q4 2021, up from 32 in Q3 2021.
  • Funds reported $16M of ProShares Ultra NASDAQ Biotechnology stock for Q4 2021, down 71% quarter-over-quarter.
  • 12 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q4 2021 and 6 closed out, a net change of +6 holders.
  • The largest ProShares Ultra NASDAQ Biotechnology buyer in Q4 2021 was Citadel Advisors, an estimated $2.49M added.
  • The largest ProShares Ultra NASDAQ Biotechnology seller in Q4 2021 was Howard Capital Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q4 2021.